HU911827D0 - Cns compounds having pharmacological effectivity - Google Patents

Cns compounds having pharmacological effectivity

Info

Publication number
HU911827D0
HU911827D0 HU911827A HU182791A HU911827D0 HU 911827 D0 HU911827 D0 HU 911827D0 HU 911827 A HU911827 A HU 911827A HU 182791 A HU182791 A HU 182791A HU 911827 D0 HU911827 D0 HU 911827D0
Authority
HU
Hungary
Prior art keywords
effectivity
pharmacological
cns compounds
cns
compounds
Prior art date
Application number
HU911827A
Other languages
Hungarian (hu)
Other versions
HUT60726A (en
Inventor
Michael John Leach
Malcolm Stuart Nobbs
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HU911827D0 publication Critical patent/HU911827D0/en
Publication of HUT60726A publication Critical patent/HUT60726A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU911827A 1990-06-01 1991-05-31 Process for producing 3,5-diamino-6-(4-aminochlorophenyl)-1,2,4-triazine derivatives acting on central nervous system, and pharmaceutical compositions comprising such compounds HUT60726A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909012312A GB9012312D0 (en) 1990-06-01 1990-06-01 Pharmacologically active cns compounds

Publications (2)

Publication Number Publication Date
HU911827D0 true HU911827D0 (en) 1991-12-30
HUT60726A HUT60726A (en) 1992-10-28

Family

ID=10676960

Family Applications (1)

Application Number Title Priority Date Filing Date
HU911827A HUT60726A (en) 1990-06-01 1991-05-31 Process for producing 3,5-diamino-6-(4-aminochlorophenyl)-1,2,4-triazine derivatives acting on central nervous system, and pharmaceutical compositions comprising such compounds

Country Status (11)

Country Link
EP (1) EP0459829A1 (en)
JP (1) JPH0625193A (en)
AU (1) AU630811B2 (en)
CA (1) CA2043642A1 (en)
FI (1) FI912622A (en)
GB (1) GB9012312D0 (en)
HU (1) HUT60726A (en)
IE (1) IE911860A1 (en)
NZ (1) NZ238358A (en)
PT (1) PT97828B (en)
ZA (1) ZA914158B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203483D0 (en) * 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds
SK279730B6 (en) * 1992-06-12 1999-02-11 The Wellcome Foundation Ltd Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable salts
FR2699077B1 (en) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application of anticonvulsants in the treatment of neurological lesions linked to trauma.
GB9306639D0 (en) * 1993-03-30 1993-05-26 Tocris Neuramin Limited Organic compounds
GB9625795D0 (en) * 1996-12-12 1997-01-29 Smithkline Beecham Plc Novel treatment
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
GB0613836D0 (en) 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
GB0800741D0 (en) * 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DE3062603D1 (en) * 1979-06-01 1983-05-11 Wellcome Found 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
ZA803250B (en) * 1979-06-01 1982-01-27 Wellcome Found Substituded aromatic compounds
GB8328757D0 (en) * 1983-10-27 1983-11-30 Wellcome Found Chemical compounds
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt

Also Published As

Publication number Publication date
FI912622A (en) 1991-12-02
AU630811B2 (en) 1992-11-05
NZ238358A (en) 1994-02-25
ZA914158B (en) 1993-03-01
PT97828A (en) 1992-03-31
AU7809991A (en) 1991-12-05
EP0459829A1 (en) 1991-12-04
JPH0625193A (en) 1994-02-01
CA2043642A1 (en) 1991-12-02
PT97828B (en) 1998-10-30
GB9012312D0 (en) 1990-07-18
HUT60726A (en) 1992-10-28
IE911860A1 (en) 1991-12-04
FI912622A0 (en) 1991-05-31

Similar Documents

Publication Publication Date Title
AP9100313A0 (en) Compounds
GB9001245D0 (en) Compounds
HU911828D0 (en) Cns compounds having pharmaceutical effectivity
AP9100314A0 (en) Compounds
GB9009469D0 (en) Compounds
HU911827D0 (en) Cns compounds having pharmacological effectivity
GB9007965D0 (en) Compounds
GB9007967D0 (en) Compounds
GB9002834D0 (en) Compounds
GB9007738D0 (en) Compounds
GB9024944D0 (en) Therapeutically useful compounds
GB9024942D0 (en) Therapeutically useful compounds
GB9010504D0 (en) Therapeutically useful compounds
GB9010503D0 (en) Therapeutically useful compounds
GB9008589D0 (en) Pharmaceutically useful compounds
GB9008588D0 (en) Pharmaceutically useful compounds
GB9003640D0 (en) Compounds
GB9006111D0 (en) Compounds
GB9003638D0 (en) Compounds
GB9003639D0 (en) Compounds
GB9002932D0 (en) Compounds
GB9003641D0 (en) Compounds
GB9004320D0 (en) Compounds
GB9004396D0 (en) Compounds
GB9005671D0 (en) Compounds